Literature DB >> 8110761

AUA-cleaving hammerhead ribozymes: attempted selection for improved cleavage.

K L Nakamaye1, F Eckstein.   

Abstract

In order to find a ribozyme which can cleave the AUA triplet efficiently, the specificities and rates of intermolecular cleavage by the ribozyme of the satellite RNA of the barley yellow dwarf virus have been determined. Although it cleaves the AUA triplet in the plus strand of the viroid RNA, cleavage of AUC and AUU is more efficient, and AUG is essentially not cleaved. Attempts were made to increase cleavage efficiency by in vitro selection with randomization at positions 7, 10.1, and 11.1 in the core region. Fifteen clones were analyzed, two of which showed increased AUA cleavage efficiency. They have a G10.1.C11.1 base pair and a pyrimidine at position 7. This corresponds to the sequence of the consensus hammerhead ribozyme. Attempts to further increase cleavage efficiency by in vitro selection of the consensus hammerhead ribozyme with randomization of the 10 nucleotides in the core region or of the sBYDV ribozyme with 12 core nucleotides randomized were not successful.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8110761     DOI: 10.1021/bi00171a030

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

1.  Structural diversity of self-cleaving ribozymes.

Authors:  J Tang; R R Breaker
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

2.  HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture.

Authors:  B Bramlage; E Luzi; F Eckstein
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

3.  Direct selection for ribozyme cleavage activity in cells.

Authors:  Xi Chen; Lisa Denison; Matthew Levy; Andrew D Ellington
Journal:  RNA       Date:  2009-09-23       Impact factor: 4.942

Review 4.  Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects.

Authors:  R A Stull; F C Szoka
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

5.  Sequence specificity of the hammerhead ribozyme revisited; the NHH rule.

Authors:  A R Kore; N K Vaish; U Kutzke; F Eckstein
Journal:  Nucleic Acids Res       Date:  1998-09-15       Impact factor: 16.971

6.  In vitro selection of a purine nucleotide-specific hammerheadlike ribozyme.

Authors:  N K Vaish; P A Heaton; O Fedorova; F Eckstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

7.  In vitro selection of hammerhead ribozymes containing a bulged nucleotide in stem II.

Authors:  J B Thomson; S T Sigurdsson; A Zeuch; F Eckstein
Journal:  Nucleic Acids Res       Date:  1996-11-15       Impact factor: 16.971

8.  Discrimination of a single base change in a ribozyme using the gene for dihydrofolate reductase as a selective marker in Escherichia coli.

Authors:  S Fujita; T Koguma; J Ohkawa; K Mori; T Kohda; H Kise; S Nishikawa; M Iwakura; K Taira
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

Review 9.  Inhibition of gene expression with ribozymes.

Authors:  P Marschall; J B Thomson; F Eckstein
Journal:  Cell Mol Neurobiol       Date:  1994-10       Impact factor: 5.046

10.  Development of lead hammerhead ribozyme candidates against human rod opsin mRNA for retinal degeneration therapy.

Authors:  Heba E Abdelmaksoud; Edwin H Yau; Michael Zuker; Jack M Sullivan
Journal:  Exp Eye Res       Date:  2008-12-06       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.